The Promise of a Personalized Genomic Approach to Pancreatic Cancer and Why Targeted Therapies Have Missed the Mark-Reference-Cited by-同舟云学术

The Promise of a Personalized Genomic Approach to Pancreatic Cancer and Why Targeted Therapies Have Missed the Mark

Published:2011-01-11 Issue:8 Volume:35 Page:1766-1769
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Fisher William E.

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-010-0949-7.pdf

Reference12 articles.

1. Altekruse SF, Kosary CL, Krapcho M et al. eds (2010) SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD. Available at http://seer.cancer.gov/csr/ . Accessed December 2010

2. Burris HA 3rd, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

3. Neuhaus P, Riess H, Post S et al. (2008) CONKO-001: final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer. J Clin Oncol 26(suppl):abstr LBA4504

4. Moore MJ, Goldstein D, Hamm J et al (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25:1960–1966

5. Xiong HQ, Rosenberg A, LoBuglio A et al (2004) Cetuximab a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II trial. J Clin Oncol 22:2610–2616

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B;Cell Reports Medicine;2023-11

2. Immunological Effects of a Tumor Necrosis Factor Alpha–Armed Oncolytic Adenovirus;Human Gene Therapy;2015-03

3. Bacterial Quorum Sensing Molecule N-3-Oxo-Dodecanoyl-L-Homoserine Lactone Causes Direct Cytotoxicity and Reduced Cell Motility in Human Pancreatic Carcinoma Cells;PLoS ONE;2014-09-04

4. Applying next-generation sequencing to pancreatic cancer treatment;Nature Reviews Gastroenterology & Hepatology;2012-07-03

5. The cell cycle and cancer;The Journal of Pathology;2011-10-28